Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort …

A Sicras-Mainar, BG Rodríguez, S Traseira-Lugilde… - BMJ open, 2022 - bmjopen.bmj.com
Objective To determine treatment persistence and exacerbations in patients initiating inhaler
treatment with fixed-dose combinations of inhaled corticosteroids/long-acting beta-2 …

Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort …

A Sicras-Mainar, S Traseira-Lugilde… - BMJ Open, 2022 - europepmc.org
Treatment persistence and exacerbations in patients with asthma initiating treatment with
inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study. - Abstract …

[HTML][HTML] Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective …

A Sicras-Mainar, BG Rodríguez, S Traseira-Lugilde… - BMJ Open, 2022 - ncbi.nlm.nih.gov
Original research: Treatment persistence and exacerbations in patients with asthma initiating
treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study …

Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort …

A Sicras-Mainar, BG Rodríguez… - BMJ …, 2022 - search.proquest.com
Treatment persistence and exacerbations in patients with asthma initiating treatment with
inhaled corticosteroids and beta- adre Page 1 1 Sicras- Mainar A, et al. BMJ Open 2022;12:e053964 …

Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort …

A Sicras-Mainar, BG Rodríguez… - BMJ …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective To determine treatment persistence and exacerbations in patients initiating inhaler
treatment with fixed-dose combinations of inhaled corticosteroids/long-acting beta-2 …